Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Badimon

Showing results (51-60 of 192) with videos related to

Pageof 20
Sort By:
Atherosclerosis|November 2, 2001
HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levelsJ Martínez-González, J Alfón, M Berrozpe, et al.
Thrombosis and Haemostasis|October 21, 1986
Electrical aggregometry in whole blood from human, pig and rabbitA Galvez, L Badimon, J J Badimon, et al.
Thrombosis and Haemostasis|July 12, 1991
Role of thrombin in arterial thrombosis: implications for therapyJ H Chesebro, P Zoldhelyi, L Badimon, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Antithrombotic therapy in cardiovascular diseases. Future directions based on pathogenesis and riskJ H Ip, B Stein, V Fuster, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulationJ Martínez-González, B Raposo, C Rodríguez, et al.
Thrombosis and Haemostasis|June 12, 1999
Effects of statins in thrombosis and aortic lesion development in a dyslipemic rabbit modelJ Alfon, C Pueyo Palazon, T Royo, et al.
Atherosclerosis|September 17, 1999
Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitorsJ Alfon, J F Guasch, M Berrozpe, et al.
Annual Review of Medicine|January 1, 1985
Intracardiac thrombi and systemic thromboembolism: detection, incidence, and treatmentJ H Chesebro, M Ezekowitz, L Badimon, et al.
European Journal of Biochemistry|April 18, 1998
Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cellsF Vidal, C Colomé, J Martínez-González, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 7, 2001
Mitogen-induced p53 downregulation precedes vascular smooth muscle cell migration from healthy tunica media and proliferationA Rodríguez-Campos, P Ruiz-Enríquez, S Faraudo, et al.
Pageof 20

Showing results (51-60 of 192) with videos related to

Sort By:
Pageof 20
Atherosclerosis|November 2, 2001
HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levelsJ Martínez-González, J Alfón, M Berrozpe, et al.
Thrombosis and Haemostasis|October 21, 1986
Electrical aggregometry in whole blood from human, pig and rabbitA Galvez, L Badimon, J J Badimon, et al.
Thrombosis and Haemostasis|July 12, 1991
Role of thrombin in arterial thrombosis: implications for therapyJ H Chesebro, P Zoldhelyi, L Badimon, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Antithrombotic therapy in cardiovascular diseases. Future directions based on pathogenesis and riskJ H Ip, B Stein, V Fuster, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 23, 2001
3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition prevents endothelial NO synthase downregulation by atherogenic levels of native LDLs: balance between transcriptional and posttranscriptional regulationJ Martínez-González, B Raposo, C Rodríguez, et al.
Thrombosis and Haemostasis|June 12, 1999
Effects of statins in thrombosis and aortic lesion development in a dyslipemic rabbit modelJ Alfon, C Pueyo Palazon, T Royo, et al.
Atherosclerosis|September 17, 1999
Nitric oxide synthase II (NOS II) gene expression correlates with atherosclerotic intimal thickening. Preventive effects of HMG-CoA reductase inhibitorsJ Alfon, J F Guasch, M Berrozpe, et al.
Annual Review of Medicine|January 1, 1985
Intracardiac thrombi and systemic thromboembolism: detection, incidence, and treatmentJ H Chesebro, M Ezekowitz, L Badimon, et al.
European Journal of Biochemistry|April 18, 1998
Atherogenic concentrations of native low-density lipoproteins down-regulate nitric-oxide-synthase mRNA and protein levels in endothelial cellsF Vidal, C Colomé, J Martínez-González, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 7, 2001
Mitogen-induced p53 downregulation precedes vascular smooth muscle cell migration from healthy tunica media and proliferationA Rodríguez-Campos, P Ruiz-Enríquez, S Faraudo, et al.
Pageof 20